Literature DB >> 10655143

Creatine kinase in human retinal pigment epithelium.

B G Kennedy1, B E Haley, N J Mangini.   

Abstract

Retinal pigment epithelial ion transport activity, and consequent ATP consumption vary significantly as a function of photoreceptor activity. In a variety of cell types, ATP levels are maintained during high-energy usage by phosphocreatine hydrolysis, catalysed by the enzyme creatine kinase. The present work was designed to assess the importance of creatine kinase in retinal pigment epithelial cell metabolism. To this end, activity measurements, non-denaturing gel electrophoresis, Western blot analysis and immunohistochemistry were used to characterize creatine kinase in retinal pigment epithelium. Total creatine kinase activity in the retinal pigment epithelium is approximately 0.05 micromol ATP mg protein(-1) min(-1). The bulk of this activity was mediated by the B-CK isoform. However, by immunoblotting, non-denaturing gel electrophoresis and immunohistochemistry, the presence of the M-CK isoform of creatine kinase was also detected. The M-CK isoform was plasma membrane associated and predominately localized to the apical surface. Creatine kinase in the retinal pigment epithelium could function in a spatial energy shuttle that helps to sustain apical plasma membrane ion transport activity. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10655143     DOI: 10.1006/exer.1999.0766

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  2 in total

1.  Expression of transient receptor potential vanilloid channels TRPV5 and TRPV6 in retinal pigment epithelium.

Authors:  Brian G Kennedy; Asad J Torabi; Rafal Kurzawa; Stephen F Echtenkamp; Nancy J Mangini
Journal:  Mol Vis       Date:  2010-04-14       Impact factor: 2.367

2.  Proinflammatory cytokines trigger biochemical and neurochemical changes in mouse retinal explants exposed to hyperglycemic conditions.

Authors:  Gaganashree Shivashankar; Julie C Lim; Monica L Acosta
Journal:  Mol Vis       Date:  2020-04-11       Impact factor: 2.367

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.